CD44 isoform switching in cancer cells as well as normal cells happens in response to some stimuli like oxidative stress [11], activation of signal transduction pathways especially MAP kinases [12, 13], epigenetics [14] or upon activation of resting lymphocytes [15]. Here, CD44 is linked to cancer.